登录 注册 会员服务 联系我们

A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals

  • Published:2022-10 Issue: Volume:240 Page:114596
  • ISSN:0223-5234
  • Container-title:European Journal of Medicinal Chemistry
  • language:en
  • Short-container-title:European Journal of Medicinal Chemistry

Author:

Alugubelli Yugendar R.,Geng Zhi Zachary,Yang Kai S.,Shaabani Namir,Khatua Kaustav,Ma Xinyu R.,Vatansever Erol C.,Cho Chia-Chuan,Ma Yuying,Xiao Jing,Blankenship Lauren R.,Yu Ge,Sankaran Banumathi,Li Pingwei,Allen Robert,Ji Henry,Xu Shiqing,Liu Wenshe RayORCID

Funder

National Institutes of Health

Office of Science

Howard Hughes Medical Institute

Texas A and M University

US Department of Energy

U.S. Department of Health and Human Services

Welch Foundation

National Institute of General Medical Sciences

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDA approved fluorine-containing drugs in 2023;Chinese Chemical Letters;2024-11

2. How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents;European Journal of Medicinal Chemistry;2024-11

3. SARS-CoV-2 replication and drug discovery;Molecular and Cellular Probes;2024-10

4. 3-chymotrypsin-like protease in SARS-CoV-2;Bioscience Reports;2024-08

5. Lessons learnt from broad-spectrum coronavirus antiviral drug discovery;Expert Opinion on Drug Discovery;2024-07-30
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3